NOVONORM 0,5 MG TBL NOB 90

What is the maximum co-payment for NOVONORM?

If the insurance company contributes, the maximum co-payment is 274,92 Kč. The maximum pharmacy price is 372,49 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, zkontrolujte ale specializaci předepisujího lékaře níže.

Does NOVONORM have a counted co-payment set?

No, this medicine has no counted co-payment.

How much does the insurance company pay for one dispensed reimbursed pack?

97,57 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

The medicine has no indication restriction. Its reimbursement is not conditional on a specific diagnosis or clinical condition.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe NOVONORM?

diabetology
endocrinology
internal medicine

What is the composition of NOVONORM?

Repaglinid (0,5 mg), neznámá látka s kódem 3755, hydrogenfosforečnan vápenatý, kukuřičný škrob, neznámá látka s kódem 4680, povidon, glycerol 85%, magnesium-stearát, meglumin, neznámá látka s kódem 1159. More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Which medicines are similar to NOVONORM?

The medicine belongs to ATC group A10BX02 – REPAGLINID. Medicines with the same active substance can be found here.

Who manufactures NOVONORM?

Novo Nordisk A/S, Bagsvaerd (DK)

Is the medicine in shortage?

The latest report from the manufacturer is from 11. 4. 2024. Production was terminated with effect from 31. 10. 2024. The manufacturer lists medicines with the following code as a potential substitute: